Início > BIGG > Resultado da busca

    Resultados: 3

    VA/DoD clinical practice guideline for the management of headache

    U.S. Government. USA Department of Defense. USA Department of Veterans Affairs.
    The VA and DoD Evidence-Based Practice Work Group (EBPWG) was established and first chartered in 2004, with a mission to advise the VA/DoD Health Executive Committee “on the use of clinical and epidemiological evidence to improve the health of the population . . .” across the Veterans Health Administ...
    Cefaleia/tratamento farmacológico, Cefaleia/classificação, Assistência Centrada no Paciente/normas, Estimulação Elétrica Nervosa Transcutânea, Antagonistas de Receptores de Angiotensina/uso terapêutico, Inibidores da Enzima Conversora de Angiotensina/uso terapêutico, Antidepressivos/uso terapêutico, Anticonvulsivantes/uso terapêutico, Antagonistas Adrenérgicos beta/uso terapêutico, Cefaleia/terapia
    Texto completo

    Headaches in over 12s: diagnosis and management

    England. National Institute for Health and Care Excellence.
    This guideline covers advice on the diagnosis and management of tension-type headache, migraine (including migraine with aura and menstrual-related migraine), cluster headache and medication overuse headache in young people (aged 12 years and older) and adults. It aims to improve the recognition and mana...
    Cefaleia/diagnóstico, Cefaleia/terapia, Cefaleia/tratamento farmacológico, Topiramato/uso terapêutico, Amitriptilina/uso terapêutico, Pizotilina/uso terapêutico
    Texto completo

    European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention

    Sacco, S; Bendtsen, L; Ashina, M; Reuter, U; Terwindt, G; Mitsikostas, DD; Martelletti, P.
    J. Head. Pain; 20 (6), 2019
    BACKGROUND AND AIM: Monoclonal antibodies acting on the calcitonin gene-related peptide or on its receptor are new drugs to prevent migraine. Four monoclonal antibodies have been developed: one targeting the calcitonin gene-related peptide receptor (erenumab) and three targeting the calcitonin gene-relat...
    Transtornos de Enxaqueca, Transtornos de Enxaqueca/diagnóstico, Transtornos de Enxaqueca/tratamento farmacológico, Transtornos de Enxaqueca/terapia, Transtornos de Enxaqueca/prevenção & controle, Receptores de Peptídeo Relacionado com o Gene de Calcitonina/uso terapêutico, Peptídeo Relacionado com Gene de Calcitonina/uso terapêutico, Cefaleia, Cefaleia/tratamento farmacológico, Cefaleia/diagnóstico, Cefaleia/terapia, Cefaleia/prevenção & controle
    Texto completo (link principal)     Texto completo (link alternativo)